The Legal Cannabis and CBD Markets are Gaining Traction

NEW YORK, April 17, 2017 /PRNewswire/ --

According to a report published by Grand View Research, the global medical cannabis market size was valued at $11.4 billion in 2015, and is expected to reach $55.8 billion by 2025, or with a compound annual growth rate of 17.1 percent during the forecast period. The accelerating pace of cannabis legalization is considered as one of the major factors that drive the growth of the legal cannabis market. Last year, states such as Arkansas, Florida, North Dakota, Ohio, and Pennsylvania have legalized cannabis for medical use, or now bringing the total number of states where medical cannabis is legal to 28. ChineseInvestors.com, Inc. (OTC: CIIX), Canopy Growth Corporation (OTC: TWMJF), Mentor Capital, Inc. (OTC: MNTR), Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), Kush Bottles, Inc. (OTC: KSHB)

Cannabidial (CBD) is one of the most prevalent compounds in the cannabis plant and it is considered to have significant medical benefits. CBD does have psychoactive effects and can be derived from hemp plants or marijuana plants. Matt Karnes of Greenwave Advisors is optimistic about the growth of the CBD market saying, "In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now there are 15 states that allow CBD only - this is in addition to the 28 states plus DC that have legalized medical marijuana."

ChineseInvestors.com, Inc. (OTCQB: CIIX) on March 30th, announced that its investment in Breakwater MB, LLC, a cannabis-focused investment and consulting company. Building on the success that CIIX enjoyed through its investment in early-stage firm Medicine Man Technologies, the Company is pleased to announce another strategic investment in the cannabis industry.

Breakwater MB was formed by CIIX board member and former CFO, Paul Dickman as a means to invest capital in and provide consulting services to private, cannabis-focused companies as they transition into the public market. The invested capital will primarily be used to cover the costs of becoming a publicly traded company, a strategy CIIX expects will provide significant investment appreciation and opportunity for liquidity. All opportunities will be evaluated by the investment committee comprised of CIIX CEO, Warren Wang, Medicine Man Technologies (OTCQB: MDCL) CEO, Andy Williams, and Paul Dickman, the CFO of Medicine Man and managing member of Breakwater MB.

"By focusing on these transitional phase investments, it's our expectation that investors in Breakwater MB will enjoy significant capital appreciation in its investment due to the arbitrage in value between private and public companies, the growth through access to the capital markets, the firm's expertise and established network, as well as short-term liquidity due to investing in newly formed publicly traded companies," states Dickman.

Canopy Growth Corporation (OTC: TWMJF) on April 3rd announced that the Company has entered into an agreement to acquire rTrees Producers Limited ("rTrees") ("the Agreement"). rTrees is a late-stage ACMPR applicant based in Yorkton, Saskatchewan. Leveraging the award-winning emerging global brand, Tweed, and paying tribute to the vast prairie grasslands, rTrees will operate as Tweed Grasslands, producing high-quality Western-grown products to support the Tweed brand and the new flagship Tweed Main Street online store.

Mentor Capital, Inc. (OTCQB: MNTR) revealed on April 13th that it has initiated funding for its GlauCanna venture for the use of medical marijuana in the treatment of glaucoma patients. Mentor will provide funding and business management for any commercial development and holds an 80% interest. Mentor CEO, Chet Billingsley explains, "All current medicines in the $2.4 billion glaucoma market act on the same receptor family to reduce the intra-ocular pressure. Once that receptor is saturated, no further progress is made and pressure often increases again, destroying vision. Surgically installing valves in the eye or drilling out drainage pathways with a laser also often have time limited effectiveness. By leveraging the alternative receptor pathway of certain cannabis components Dr. Mandelkorn has observed a 40% reduction in intra-ocular pressure, back into the normal range, amongst patients that had otherwise saturated their existing eye medicine effectiveness. In an illustrative layman's example, a patient at the limit of other medication effectiveness had vision with corrected glasses reduced to 20/200 because of glaucoma damage. After a particular two week medical marijuana regime, the vision improved to 20/50 with observed tissue healing."

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Our lead product candidate, anabasum, is a novel synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation, and fibrotic processes. On April 5th, the company explained that the Company will be proceeding with a single Phase 3 study to support a New Drug Application ("NDA") for anabasum for the treatment of diffuse cutaneous systemic sclerosis.

Kush Bottles, Inc. (OTCQB: KSHB) is a provider of packaging, supplies, accessories and branding solutions for the regulated cannabis industry. On March 1st, the company announced that it has added two new distribution partners in Hawaii and Puerto Rico, two key medical cannabis markets. The move will significantly enhance the company's ability to attract and service new customers in these emerging markets. The company's Hawaii distribution partner will service the island's dispensaries that provide products to registered patients. Hawaii's reciprocity program will also allow sales to patients with valid medical marijuana cards who are visiting from other states. According to the Hawaii Department of Business, Economic Development and Tourism, Hawaii had approximately 9 million tourists visit in 2016.

Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com 

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. We also do not include any personal opinions or commentary. For this release, FinancialBuzz.com expects to be compensated three thousand dollars for financial news dissemination and pr services by chineseInvestors.com, Inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com has signed a two year agreement with chineseinvestors.com inc. for one hundred thousand restricted common shares for continued financial news dissemination and pr services. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.

For further information:
Media Contact e-mail: [email protected]
+1-877-601-1879

Url: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com